Wells Fargo & Company Inhibrx, Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Inhibrx, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 14,486 shares of INBX stock, worth $205,266. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,486

Previous 23,618 38.67%

Holding current value

$205,266

Previous $897,000 43.59%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$32.76 - $39.56 $299,164 - $361,261	-9,132 Reduced 38.67%	14,486 $506,000
Q4 2023 Feb 09, 2024	SELL	$14.5 - $38.0 $283,431 - $742,786	-19,547 Reduced 45.28%	23,618 $897,000
Q3 2023 Nov 13, 2023	SELL	$15.75 - $26.31 $58,275 - $97,347	-3,700 Reduced 7.9%	43,165 $792,000
Q2 2023 Aug 15, 2023	BUY	$16.96 - $27.82 $70,231 - $115,202	4,141 Added 9.69%	46,865 $1.22 Million
Q1 2023 May 12, 2023	BUY	$18.45 - $27.14 $650,620 - $957,064	35,264 Added 472.71%	42,724 $806,000

Q4 2022 Feb 13, 2023	SELL	$20.18 - $33.33 $27,404 - $45,262	-1,358 Reduced 15.4%	7,460 $183,000
Q3 2022 Nov 14, 2022	BUY	$11.58 - $24.73 $18,423 - $39,345	1,591 Added 22.01%	8,818 $158,000
Q2 2022 Aug 12, 2022	SELL	$8.52 - $25.26 $43,537 - $129,078	-5,110 Reduced 41.42%	7,227 $82,000
Q1 2022 May 16, 2022	SELL	$19.89 - $43.18 $207,194 - $449,806	-10,417 Reduced 45.78%	12,337 $275,000
Q4 2021 Feb 14, 2022	SELL	$26.75 - $46.02 $172,136 - $296,138	-6,435 Reduced 22.05%	22,754 $994,000
Q3 2021 Nov 15, 2021	BUY	$25.18 - $37.81 $445,484 - $668,934	17,692 Added 153.88%	29,189 $972,000
Q2 2021 Aug 16, 2021	BUY	$14.69 - $27.52 $19,302 - $36,161	1,314 Added 12.9%	11,497 $316,000
Q1 2021 May 13, 2021	SELL	$16.27 - $41.26 $180,043 - $456,583	-11,066 Reduced 52.08%	10,183 $205,000
Q4 2020 Feb 09, 2021	BUY	$15.96 - $50.0 $224,222 - $702,450	14,049 Added 195.13%	21,249 $701,000
Q3 2020 Nov 05, 2020	BUY	$16.77 - $20.65 $120,744 - $148,680	7,200 New	7,200 $130,000

Others Institutions Holding INBX

# of Institutions

132

Shares Held

35.5M

Call Options Held

64.8K

Put Options Held

91.3K

View Full List

About Inhibrx, Inc.

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $553M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

More about INBX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Inhibrx, Inc. Transaction History